// App-Quantinova.ai

6599 : Serum tumor marker utilization in patients with advanced solid tumors.

Researchers

Presenter

  • Melissa Kate Accordino

Principal Investigators

  • Jason Dennis Wright

  • Dawn L. Hershman

  • Sowmya Vasan

  • Alfred I. Neugut

  • Ana Isabel Tergas

Medical Centers

  • NewYork-Presbyterian Hospital, New York, NY

  • Mailman School of Public Health, Columbia University, New York, NYColumbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, NYColumbia Univ Coll of Physicians and Surgeons, New York, NY

  • Columbia Coll of Phys and Surg, New York, NY

  • Columbia University Medical Center, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cancer antigen 15-3

  • Alpha-fetoprotein

  • Carcinoembryonic antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved